Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance

Fig. 1

Validating the expression of Her2 in OS. (A) UMAP visualization of cells analyzed by scRNA-seq and integrated across 5 primary osteosarcomas. Clusters were annotated for their cell types as predicted using canonical markers. (B) Log-normalized expression of ERBB2(Her2). (C) The expression of Her2 in osteosarcoma derived from different patients assessed by immunohistochemistry assay. Scale bar: 100 μm. (D) Percentage of Her2-positive areas per osteosarcoma tissue. (E) Expression of Her2 in U2OS and 143B cells determined by Western blot. (F, G) The expression of Her2 in various osteosarcoma cell lines was detected by flow cytometry

Back to article page